Cargando…
Sudden Cardiac Death in Ischaemic Cardiomyopathy and the Primary Prevention ICD: Time for a More a Personalised Approach?
Guidelines recommend primary prevention implantable cardioverter defibrillator (PPICD) for left ventricular ejection fraction (LVEF) <35% only after 3 months of optimal medical therapy (OMT) or 6 weeks after acute MI with persistent LVEF dysfunction. A 73-year-old woman presented with decompensat...
Autores principales: | Ezad, Saad M, Babu, Girish, O’Kane, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311393/ https://www.ncbi.nlm.nih.gov/pubmed/37398871 http://dx.doi.org/10.15420/icr.2022.14 |
Ejemplares similares
-
Revascularisation for Ischaemic Cardiomyopathy
por: Li Kam Wa, Matthew E, et al.
Publicado: (2023) -
Contemporary Management of Stent Failure: Part One
por: Pal, Nikhil, et al.
Publicado: (2019) -
Risk Stratification for Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy
por: Akhtar, M., et al.
Publicado: (2019) -
Subcutaneous implantable cardioverter-defibrillator (S-ICD) for secondary prevention of sudden cardiac death
por: Kempa, Maciej, et al.
Publicado: (2016) -
The ischaemic constellation: an alternative to the ischaemic cascade—implications for the validation of new ischaemic tests
por: Maznyczka, Annette, et al.
Publicado: (2015)